In Brief: Boehringer Mannheim/PerSeptive Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Boehringer Mannheim/PerSeptive Biosystems: Enter strategic alliance under which Boehringer gains worldwide co-exclusive distribution rights to Framingham, Massachusetts-based PerSeptive's Poros chromatography columns. In exchange, Boehringer agrees to purchase $2 mil. of PerSeptive common stock for $12.69 per share and obtains an option to buy an additional $1 mil. worth at the same price during the next 24 months. The companies say they also will conduct joint research and development of "advanced biochemical tools and reagents"...